🏛️ Verified NIH Record • Updated 2024-11-22

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD (NCT06704321)

🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Valbiotis

🩺 Plain-English Summary (8th-Grade Level)

This clinical trial aims to investigate the effects of TOTUM-448, a mix of 5 plant extracts and choline, consumed at the daily regimen of two times per day, on liver fat content, cardiometabolic risk factors and gut microbiota among both men and women with MASLD.

Who can join: Review the eligibility criteria below.

Location: Institut sur la nutrition et les aliments fonctionnels (INAF) — Québec, Quebec

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

  • Institut sur la nutrition et les aliments fonctionnels (INAF) — Québec, Quebec

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
🏛️ View Official NIH Record ↗